183 related articles for article (PubMed ID: 23307955)
21. Anti-angiogenic and anti-inflammatory effects of CD200-CD200R1 axis in oxygen-induced retinopathy mice model.
Hu Y; Wei T; Gao S; Cheng Q
Inflamm Res; 2019 Nov; 68(11):945-955. PubMed ID: 31444514
[TBL] [Abstract][Full Text] [Related]
22. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
[TBL] [Abstract][Full Text] [Related]
24. Differences between rat strains in models of retinopathy of prematurity.
Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM
Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168
[TBL] [Abstract][Full Text] [Related]
25. Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor.
Miki K; Miki A; Matsuoka M; Muramatsu D; Hackett SF; Campochiaro PA
Ophthalmology; 2009 Sep; 116(9):1748-54. PubMed ID: 19643496
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.
Nambu H; Umeda N; Kachi S; Oshima Y; Akiyama H; Nambu R; Campochiaro PA
J Cell Physiol; 2005 Jul; 204(1):227-35. PubMed ID: 15648096
[TBL] [Abstract][Full Text] [Related]
27. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
28. Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway.
Du W; Yu W; Huang L; Zhao M; Li X
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1990-8. PubMed ID: 22408005
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
[TBL] [Abstract][Full Text] [Related]
30. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
[TBL] [Abstract][Full Text] [Related]
31. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.
Ozaki H; Seo MS; Ozaki K; Yamada H; Yamada E; Okamoto N; Hofmann F; Wood JM; Campochiaro PA
Am J Pathol; 2000 Feb; 156(2):697-707. PubMed ID: 10666398
[TBL] [Abstract][Full Text] [Related]
32. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
33. Expression and role of VEGF in the adult retinal pigment epithelium.
Ford KM; Saint-Geniez M; Walshe T; Zahr A; D'Amore PA
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9478-87. PubMed ID: 22058334
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.
Zhao S; Huang L; Wu J; Zhang Y; Pan D; Liu X
Mol Vis; 2009 Jun; 15():1231-42. PubMed ID: 19536308
[TBL] [Abstract][Full Text] [Related]
35. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
37. Reduced β‑2‑glycoprotein І inhibits hypoxia‑induced retinal angiogenesis in neonatal mice through the vascular endothelial growth factor pathway.
Liu H; Zhou S; Denyer G; Meng Z; Chen R; Lv L; Li C; Yu D; Yu P
Mol Med Rep; 2015 Feb; 11(2):1025-30. PubMed ID: 25374014
[TBL] [Abstract][Full Text] [Related]
38. Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.
Huang H; Van de Veire S; Dalal M; Parlier R; Semba RD; Carmeliet P; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7565-73. PubMed ID: 21873682
[TBL] [Abstract][Full Text] [Related]
39. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
Huang H; Shen J; Vinores SA
PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
[TBL] [Abstract][Full Text] [Related]
40. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.
Feeney SA; Simpson DA; Gardiner TA; Boyle C; Jamison P; Stitt AW
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):839-47. PubMed ID: 12556420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
